Showing results (191-200 of 212) with videos related to
Sort By:
Pageof 22
The Analyst|February 19, 2026
Studying the evolutionary potential of ancestral aryl sulfatases in the alkaline phosphatase family with droplet microfluidicsBernard D G Eenink, Josephin M Holstein, Magdalena Heberlein, et al.Analytical and Bioanalytical Chemistry|January 27, 2026
Neutralizing activity analysis of mimotopes against porcine epidemic diarrhea virus (PEDV) spike proteinTae-Hun Kim, Jae-Yeon Park, Soonil Kwon, et al.Journal of Materials Chemistry. B|March 27, 2024
A one-step immunoassay based on switching peptides for diagnosis of porcine epidemic diarrhea virus (PEDV) using screened Fv-antibodiesTae-Hun Kim, Jae-Yeon Park, Jaeyong Jung, et al.ACS Synthetic Biology|November 19, 2019
High-Throughput, Lysis-Free Screening for Sulfatase Activity Using Escherichia coli Autodisplay in MicrodropletsBert van Loo, Magdalena Heberlein, Philip Mair, et al.Molecular Psychiatry|October 4, 2024
Missense mutation in the activation segment of the kinase CK2 models Okur-Chung neurodevelopmental disorder and alters the hippocampal glutamatergic synapseJose M Cruz-Gamero, Demetra Ballardin, Barbara Lecis, et al.Bioconjugate Chemistry|May 19, 2022
Antibody-Mediated Screening of Peptide Inhibitors for Monoamine Oxidase-B (MAO-B) from an Autodisplayed FV LibraryJeong Soo Sung, Ji-Hong Bong, Tae Gyeong Yun, et al.European Journal of Medicinal Chemistry|May 29, 2013
Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2Jean Guillon, Marc Le Borgne, Charlotte Rimbault, et al.Biosensors & Bioelectronics|November 23, 2023
One-step immunoassay of SARS-CoV-2 using screened Fv-antibodies and switching peptidesJaeyong Jung, Jeong Soo Sung, Ji-Hong Bong, et al.Bioorganic & Medicinal Chemistry|April 26, 2024
1,2,3-Triazole-totarol conjugates as potent PIP5K1α lipid kinase inhibitorsSamer Haidar, Ángel Amesty, Sandra Oramas-Royo, et al.Archiv Der Pharmazie|July 12, 2002
Inhibition of CYP 17, a new strategy for the treatment of prostate cancerRolf W Hartmann, Peter B Ehmer, Samer Haidar, et al.Pageof 22